Glatopa Injection, Solution
Product Images NDC 0781-3234

20 FDA label images from Sandoz Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Glatopa (NDC 0781-3234). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural-formula (Glatopa 01)

Structural-formula (Glatopa 01)
Chemical structure showing the molecular components of Glatiramer Acetate, including amino acid residues (Glu, Ala, Lys, Tyr) linked to acetate groups, with a CAS number 147245-92-9 displayed below.*
FDA Label Image

Figure_01 (Glatopa 02)

Figure_01 (Glatopa 02)
A survival curve chart comparing the percentage of second exacerbation over time between two groups: Glatiramer Acetate Injection 20 mg (n=243) and placebo (n=238). The x-axis shows days up to 1080, and the y-axis shows the second exacerbation percentage. The Glatiramer Acetate group has a lower rate of exacerbation than placebo, with a hazard ratio of 0.55 and p-value of 0.0005 indicated on the chart.*
FDA Label Image

Figure_02 (Glatopa 03)

Figure_02 (Glatopa 03)
A line graph depicting the cumulative median number of enhancing lesions over nine months comparing Glatiramer Acetate Injection and placebo. The x-axis represents months, and the y-axis shows the median cumulative lesion count. Two lines are plotted: a gray line for Glatiramer Acetate Injection and a black line for placebo, with the placebo line rising more steeply after month 2.*
FDA Label Image

Figure-a (Glatopa 04)

Figure-a (Glatopa 04)
An illustration showing components of a Glatopa injection kit, including a sharps disposal container with a biohazard symbol, a syringe in a blister package labeled for injection, cotton balls, alcohol wipes, and an injection diary. The items are arranged and labeled for identification.*
FDA Label Image

Figure-b (Glatopa 05)

Figure-b (Glatopa 05)
An instructional illustration showing a pair of hands holding the cap of an injection pen or syringe, demonstrating the removal or handling of the cap. The image is related to the preparation of Glatopa (Glatiramer Acetate) injection for subcutaneous use.*
FDA Label Image

Figure-c-abdomen (Glatopa 06)

Figure-c-abdomen (Glatopa 06)
An anatomical diagram showing the front view of a human torso, highlighting the navel and the subcutaneous area around the abdomen where an injection can be administered. This illustration is likely used to demonstrate the injection site for Glatopa (Glatiramer Acetate) subcutaneous solution.*
FDA Label Image

Figure-c-hips-and-arms (Glatopa 07)

Figure-c-hips-and-arms (Glatopa 07)
Illustration showing the posterior view of the human torso and arms with shaded areas indicating recommended sites for subcutaneous injection, likely corresponding to the injection route for Glatopa (glatiramer acetate) solution.*
FDA Label Image

Figure-c-arms (Glatopa 08)

Figure-c-arms (Glatopa 08)
An instructional illustration showing a person preparing to administer a subcutaneous injection of Glatiramer Acetate (Glatopa). The image highlights the upper arm as the injection site for the solution.*
FDA Label Image

Figure-c-thighs (Glatopa 09)

Figure-c-thighs (Glatopa 09)
An instructional illustration showing the recommended injection sites for subcutaneous administration on the front and outer sides of the thighs.*
FDA Label Image

Figure-d (Glatopa 10)

Figure-d (Glatopa 10)
An instructional illustration showing a hand holding a syringe at the lower arm, demonstrating proper subcutaneous injection technique for a medication like Glatopa (glatiramer acetate) injection solution.*
FDA Label Image

Figure-e (Glatopa 11)

Figure-e (Glatopa 11)
Instructional diagram showing three sequential hand illustrations demonstrating how to hold and position a syringe or injection device for administration. Each image focuses on varied grips and angles, likely for correct subcutaneous injection technique.*
FDA Label Image

Figure-f (Glatopa 12)

Figure-f (Glatopa 12)
Illustration showing a close-up of a hand pinching the skin, likely demonstrating the technique for subcutaneous injection, in line with the Glatopa injection product usage.*
FDA Label Image

Figure-g (Glatopa 13)

Figure-g (Glatopa 13)
An instructional illustration depicting a person preparing a subcutaneous injection by inserting a syringe needle into the skin of their forearm. This image is relevant for subcutaneous administration of Glatopa (Glatiramer Acetate) injection solution.*
FDA Label Image

Figure-h (Glatopa 14)

Figure-h (Glatopa 14)
An instructional illustration showing the subcutaneous injection of a medication into the thigh. The image depicts a person lifting the skin on their thigh with one hand while holding a syringe with the other hand, preparing to administer an injection.*
FDA Label Image

Figure-i (Glatopa 15)

Figure-i (Glatopa 15)
An instructional illustration showing a hand injecting a subcutaneous injection into the skin, likely demonstrating the administration technique for Glatopa (glatiramer acetate) injection solution.*
FDA Label Image

Figure-j (Glatopa 16)

Figure-j (Glatopa 16)
An instructional line drawing depicting a hand holding a syringe above an injection site on the upper arm, demonstrating the subcutaneous injection technique for administering medication.*
FDA Label Image

Figure-k (Glatopa 17)

Figure-k (Glatopa 17)
Instructional illustration showing a hand inserting or removing an object into or from a sleeve or pocket. The image is a simple black-and-white line drawing, likely part of usage or administration instructions for a product.*
FDA Label Image

Figure-l (Glatopa 18)

Figure-l (Glatopa 18)
Illustration of a sharps disposal container with a biohazard symbol, used for safe disposal of needles and syringes.*
FDA Label Image

Glatopa-19 (Glatopa 19)

Glatopa-19 (Glatopa 19)
Packaging label for Glatopa 20 mg/mL (glatiramer acetate injection) by Sandoz Inc. The label indicates it is a subcutaneous injection supplied as 30 single-dose pre-filled syringes. It provides storage instructions to keep refrigerated between 2° to 8°C and protect from light. The label highlights the product is for prescription use only.*
FDA Label Image

Glatopa-20 (Glatopa 20)

Glatopa-20 (Glatopa 20)
Packaging label for Glatopa (glatiramer acetate injection) 40 mg/mL, a subcutaneous injection. The label states it contains 12 single-dose pre-filled syringes, to be used three times a week. It is distributed by Sandoz Inc and includes storage instructions to keep refrigerated between 2° to 8°C (36° to 46°F) and protected from light.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.